Vela Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 16-12-2024
- Paid Up Capital ₹ 0.22 M
as on 16-12-2024
- Company Age 12 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -46.55%
(FY 2020)
- Profit -54.55%
(FY 2020)
- Ebitda -50.55%
(FY 2020)
- Net Worth 35.00%
(FY 2020)
- Total Assets -28.30%
(FY 2020)
About Vela Biotech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.22 M, as per Ministry of Corporate Affairs (MCA) records.
Devaraj Palaniswamy and Krishnaswamy Usha serve as directors at the Company.
- CIN/LLPIN
U01119TZ2012PTC018359
- Company No.
018359
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 2012
- Date of AGM
26 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Vela Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devaraj Palaniswamy  | Director | 13-Jun-2012 | Current |
| Krishnaswamy Usha | Director | 14-Jul-2022 | Current |
Financial Performance of Vela Biotech.
Vela Biotech Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 46.55% decrease. The company also saw a substantial fall in profitability, with a 54.55% decrease in profit. The company's net worth Soared by an impressive increase of 35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vela Biotech?
In 2020, Vela Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Geniies It & Services Private LimitedActive 15 years 8 monthsDevaraj Palaniswamy and Krishnaswamy Usha are mutual person
Dima Business Solutions Private LimitedActive 5 years 6 monthsDevaraj Palaniswamy and Krishnaswamy Usha are mutual person
Toon Explainers Private LimitedActive 8 years 1 monthDevaraj Palaniswamy and Krishnaswamy Usha are mutual person
Palaniswamy Farms Private LimitedActive 11 years 4 monthsDevaraj Palaniswamy and Krishnaswamy Usha are mutual person
- G.P.S.Farms Private LimitedActive 11 years 4 months
Devaraj Palaniswamy and Krishnaswamy Usha are mutual person
- Ishvaryam Infrastructures Private LimitedActive 9 years 9 months
Devaraj Palaniswamy and Krishnaswamy Usha are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vela Biotech?
Unlock and access historical data on people associated with Vela Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vela Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vela Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
